James S. Scibetta, President at Pacira Pharmaceuticals, Inc. (PCRX), sold 40,000 shares at $38.97 ($1.5M) on 2017-01-17, disclosed to the SEC on 2017-01-19.
Open-market sale of $1.5M PCRX by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.39 | 15,003 | $576K | 37.4% |
| 2 | $38.39 | 15,003 | $576K | 37.4% |
| 3 | $38.97 | 4,997 | $195K | 12.6% |
| 4 | $38.97 | 4,997 | $195K | 12.6% |
| Total | $38.53 avg | 40,000 | $1.5M | 100% |
| Filing → |
| PCRX | SELL | 2017-06-07 | $170K | — | Filing → |
| PCRX | SELL | 2017-05-17 | $1.0M | — | Filing → |
| PCRX | SELL | 2016-11-17 | $730K | — | Filing → |